The search results include studies on:
Riboflavin overproduction (e.g., acetohydroxyacid synthase, glutathione reductase) .
Lipid biosynthesis (e.g., acetyl-CoA synthase, Δ9 desaturases) .
Genomic and metabolic engineering (e.g., promoter design, strain optimization) .
No references to lipoyl synthase or its mitochondrial isoform (AGR231C) were identified in the provided materials.
Lipoyl synthase is typically studied in bacterial and mitochondrial systems (e.g., E. coli, S. cerevisiae) for its role in lipoic acid biosynthesis. Ashbya gossypii is primarily explored for industrial applications (e.g., riboflavin, lipids), which may not align with current research on this enzyme.
The Ashbya gossypii genome (e.g., strain ATCC10895) has been sequenced , but functional studies on lipid metabolism or cofactor biosynthesis (e.g., lipoic acid) may not have been prioritized.
To address the lack of data, the following steps are suggested:
Expand the search to include:
Primary databases: PubMed, Google Scholar, SciFinder.
Keywords: "Ashbya gossypii lipoyl synthase," "AGR231C," "lipoic acid biosynthesis in Ashbya."
Gene Knockout Studies:
Validate AGR231C’s role in A. gossypii using CRISPR-Cas9 or homologous recombination.
Assess phenotypes (e.g., growth defects, cofactor deficiencies).
Protein Expression and Purification:
Recombinant production in E. coli or P. pastoris to study enzymatic activity.
Metabolomic Profiling:
Measure lipoic acid levels in wild-type vs. AGR231C-deficient strains.
| Parameter | Hypothetical Value (AGR231C) | Control (WT) | Source |
|---|---|---|---|
| Gene Expression Level | ↑ 2.5-fold (qPCR) | Baseline | [Hypothetical] |
| Lipoic Acid Content | ↓ 40% | 100% | [Hypothetical] |
| Growth Rate (Glucose) | Reduced | Normal | [Hypothetical] |
Note: This table is speculative and not supported by the provided literature.
This protein catalyzes the radical-mediated insertion of two sulfur atoms into the C-6 and C-8 positions of the octanoyl moiety bound to the lipoyl domains of lipoate-dependent enzymes, thus converting octanoylated domains into lipoylated derivatives.
KEGG: ago:AGOS_AGR231C
STRING: 33169.AAS54721
Ashbya gossypii Lipoyl synthase (LIAS) is a mitochondrial enzyme that catalyzes the insertion of sulfur atoms into octanoyl substrates to form lipoyl moieties. This enzyme is critical for the lipoylation pathway, which is essential for the function of key metabolic enzymes including pyruvate dehydrogenase complex (PDC), α-ketoglutarate dehydrogenase complex (OGDC), and the glycine cleavage system (GCS) .
The reaction involves the insertion of two sulfur atoms at the C6 and C8 positions of an octanoyl chain that is bound to a specific lysine residue of the lipoyl domain (LD) of these enzyme complexes. This modification is crucial for the proper functioning of these metabolic enzymes in the mitochondria .
A. gossypii Lipoyl synthase contains two distinct iron-sulfur cluster binding motifs that are critical for its catalytic function:
A C-X₂-C iron-sulfur cluster binding motif that coordinates a reducing [4Fe-4S] cluster, which acts as an electron source to generate the radical form of S-adenosylmethionine (SAM)
A C-X₄-C-X₅-C motif that is exclusive to lipoyl synthases and coordinates an auxiliary [4Fe-4S] cluster, which serves as the source of sulfur atoms inserted into the octanoyl substrate
These structural features enable LIAS to perform the complex radical-based chemistry required for sulfur insertion. The enzyme uses two equivalents of SAM to generate radicals at the sixth and eighth carbons of the octanoyl chain, facilitating sulfur insertion from the auxiliary [4Fe-4S] cluster .
Based on current research methodologies for similar proteins, E. coli expression systems have proven effective for recombinant production of iron-sulfur proteins like LIAS . For A. gossypii LIAS specifically, consider the following optimization strategies:
Expression vector selection: Use vectors with strong, inducible promoters (e.g., T7) that can be tightly regulated to prevent premature expression that might be toxic
Host strain selection: Choose E. coli strains optimized for iron-sulfur protein expression (e.g., BL21(DE3) derivatives supplemented with plasmids encoding iron-sulfur cluster assembly proteins)
Culture conditions:
Low-temperature induction (16-18°C)
Supplementation with iron (ferrous ammonium sulfate, 100-200 μM)
Addition of L-cysteine (200 μM) to support Fe-S cluster assembly
Anaerobic or microaerobic conditions during expression and purification
Purification strategy:
Include affinity tags that don't interfere with Fe-S cluster assembly (His₆ tag is commonly used)
Maintain anaerobic conditions during all purification steps
Include reducing agents (DTT or β-mercaptoethanol) in all buffers
For heterologous expression in A. gossypii itself, the newly developed promoter systems described in search result provide valuable tools, with the dual luciferase reporter system enabling quantitative evaluation of promoter strength.
An effective assay system for A. gossypii LIAS activity should include:
Substrate preparation: Use a truncated version of the lipoyl carrier protein (H-protein) where the octanoyl side chain is attached to the lysine through an amide bond, similar to methods described for human LIAS
Reaction components:
Reconstituted LIAS enzyme with both [4Fe-4S] clusters
S-adenosylmethionine (SAM)
Octanoylated substrate protein
Reducing system (typically sodium dithionite or a physiological electron donor)
Buffer system (typically HEPES or Tris at pH 7.5-8.0)
Detection method:
Controls:
Reactions without enzyme
Reactions without SAM
Reactions with partially reconstituted enzyme (only auxiliary or only reducing cluster)
Sample data from a typical activity assay might resemble:
| Enzyme Preparation | [4Fe-4S] Clusters Present | Relative Activity (%) |
|---|---|---|
| As-isolated LIAS | Auxiliary only | 0 |
| LIAS + ISCU reconstitution | Both | 100 |
| LIAS + ISCA2 reconstitution | Both | 95 ± 10 |
| LIAS C106A mutant | None | 0 |
| LIAS C137A mutant | Auxiliary only | 0 |
This approach provides quantitative data on LIAS activity and can be used to evaluate the effects of mutations or different reconstitution methods .
The A. gossypii lipoylation pathway shares core components with other eukaryotes but may have organism-specific features. Based on comparative studies of lipoylation pathways:
Core pathway components:
LIPT2: Transfers octanoyl groups from ACP to lipoyl domains (primarily GCSH)
LIAS: Inserts sulfur atoms into octanoyl moieties
LIPT1: Transfers lipoyl groups between proteins
Pathway organization in different organisms:
| Organism | Initial Octanoylation | Sulfur Insertion | Lipoyl Transfer |
|---|---|---|---|
| Humans | LIPT2 transfers octanoyl from ACP to GCSH | LIAS converts octanoyl to lipoyl on GCSH | LIPT1 transfers lipoyl from GCSH to E2 subunits |
| A. gossypii | Likely similar to human pathway | Performed by mitochondrial LIAS | Likely uses LIPT1 homolog |
| E. coli | LipB transfers octanoyl from ACP to lipoyl domains | LipA (bacterial LIAS) inserts sulfur | Not required (direct modification) |
Unique features of A. gossypii system:
May have adaptations related to high riboflavin production
Could have differences in regulation due to filamentous fungal metabolism
The efficient functioning of this pathway is essential for A. gossypii metabolism and potentially impacts its biotechnological applications in riboflavin production .
Iron-sulfur cluster assembly and delivery pathways are critical for LIAS function, as the enzyme requires two distinct [4Fe-4S] clusters. Research on human LIAS provides insights applicable to A. gossypii:
Cluster assembly proteins:
ISCU functions as a primary scaffold for [2Fe-2S] cluster assembly
ISCA proteins (ISCA1, ISCA2) are involved in [4Fe-4S] cluster formation
Cluster transfer preferences:
ISCU has been shown to be the most effective donor for LIAS reconstitution
Full-length ISCA2 is also effective (95 ± 10% relative to ISCU-promoted activity)
Impact on LIAS activity:
Native LIAS as isolated is typically inactive due to incomplete cluster assembly
Full reconstitution requires delivery of clusters to both the auxiliary and reducing sites
Experimental approach for A. gossypii:
Identify A. gossypii homologs of key Fe-S cluster assembly proteins
Test their ability to reconstitute A. gossypii LIAS in vitro
Use spectroscopic methods (UV-Vis, EPR) to monitor cluster assembly
Understanding these interactions is crucial for optimizing recombinant LIAS production and activity .
Several challenges can arise when working with A. gossypii LIAS:
Iron-sulfur cluster instability:
Problem: Fe-S clusters are oxygen-sensitive and can degrade during purification
Solution: Perform all steps under anaerobic conditions; use glove box or Schlenk techniques; include reducing agents in all buffers; work quickly and keep samples cold
Low yield of active enzyme:
Problem: Expression of Fe-S proteins often results in low yields of properly folded protein
Solution: Optimize expression conditions (temperature, induction time); co-express with Fe-S cluster assembly proteins; test multiple purification strategies
Insufficient cluster reconstitution:
Problem: Recombinant LIAS often lacks complete Fe-S clusters
Solution: Use effective reconstitution methods with appropriate Fe-S cluster donors; monitor reconstitution spectroscopically
Activity assessment challenges:
Problem: Complex assay systems with multiple components can be difficult to optimize
Solution: Develop robust controls; ensure adequate substrate preparation; optimize detection methods
Storage stability:
Addressing these challenges requires careful experimental design and appropriate controls to ensure reproducible results with active enzyme.
Site-directed mutagenesis is a powerful approach for investigating LIAS mechanism:
Key targets for mutagenesis:
Cluster-binding cysteines: Based on human LIAS studies, mutations like C106A (auxiliary cluster) and C137A/C141A (reducing cluster) can selectively eliminate binding at each site
Conserved residues in substrate binding pocket: Identify potential substrate-interacting residues through structural modeling
Residues involved in SAM binding: Target conserved motifs that interact with SAM
Expected effects:
Mutations in auxiliary cluster binding site (e.g., C106A) typically result in complete loss of Fe-S clusters and activity
Mutations in reducing cluster site may retain the auxiliary cluster but lose activity
Mutations affecting substrate binding may show altered kinetics without complete loss of activity
Characterization methods:
Iron quantitation to determine cluster content
EPR spectroscopy to assess cluster type and environment
Activity assays to measure functional impact
LC-MS to detect intermediate formation
Experimental design example:
| Mutation | Target Site | Expected Effect | Characterization Methods |
|---|---|---|---|
| C106A | Auxiliary cluster | Loss of all clusters | Fe quantitation, EPR, activity assay |
| C137A | Reducing cluster | Retention of auxiliary cluster only | Fe quantitation, EPR, activity assay |
| C137A-C141A | Reducing cluster | Confirmation of cluster loss | Fe quantitation, EPR, activity assay |
| S-to-A | Non-cysteinyl cluster ligand | Altered cluster properties | EPR, activity assay |
This approach has provided valuable insights into human LIAS mechanism and could be adapted for A. gossypii LIAS .
LIAS activity has significant implications for A. gossypii biotechnology applications:
Riboflavin production:
Biolipid production:
A. gossypii has been engineered for single cell oil (SCO) production
Lipoylated enzymes influence acetyl-CoA and NADPH availability, which are critical for lipid biosynthesis
Engineering strains with optimized lipoylation could increase lipid yields beyond current levels (up to 70% of cell dry weight)
Recombinant protein production:
Other metabolites:
Understanding and optimizing LIAS function could therefore be a valuable target for enhancing various biotechnological applications of A. gossypii.
Modifying LIAS expression can have complex effects on cellular metabolism:
Effects of increased LIAS expression:
May increase lipoylation of target enzymes if other pathway components (LIPT1, LIPT2) and iron-sulfur cluster assembly machinery are not limiting
Could enhance activity of PDC, OGDC, BCKDC, and GCS, potentially increasing flux through these pathways
Might lead to higher acetyl-CoA production, benefiting pathways like lipid synthesis
In humans, overexpression of LIP1 has shown varied effects depending on the genetic background, suggesting complex regulatory interactions
Effects of decreased LIAS expression:
Competitive iron-sulfur cluster utilization:
LIAS competes with other Fe-S proteins for limited Fe-S clusters
In contexts where Fe-S cluster assembly is limiting, overexpression of abundant Fe-S proteins like aconitase (ACO) can reduce LIAS activity
This has been demonstrated in Arabidopsis, where deletion of ACO3 suppressed phenotypes of GRXS15 mutation by redirecting Fe-S clusters to LIAS
Potential metabolic engineering strategy:
| Approach | Expected Effect | Potential Applications |
|---|---|---|
| LIAS overexpression | Increased lipoylation if other components not limiting | Enhanced central metabolism for precursor supply |
| Co-expression with Fe-S assembly proteins | Improved LIAS activity through better Fe-S cluster availability | More robust metabolic engineering strains |
| Reduced expression of competing Fe-S proteins | Redirection of Fe-S clusters to LIAS | Balanced Fe-S protein function |
| Fine-tuning LIAS expression with condition-specific promoters | Optimized lipoylation under different growth conditions | Adaptable production strains |
These engineering approaches would need to be carefully tested as the outcomes may be difficult to predict due to the complex regulatory networks involved .
Recent advances in A. gossypii promoter characterization provide valuable tools for LIAS expression control:
Newly characterized promoters:
Promoter strength comparison:
| Promoter | Relative Strength Compared to GPD1 | Regulation |
|---|---|---|
| GPD1 (TDH3) | Reference (100%) | Constitutive |
| TEF | Higher than GPD1 | Constitutive |
| RPL4B | Similar to GPD1 | Constitutive |
| PGI1 | Lower than GPD1 | Constitutive |
| Additional promoters | Varied strengths | Some carbon source-regulatable |
Implementation strategy:
For basic research: Use constitutive promoters of appropriate strength to achieve desired LIAS expression levels
For metabolic engineering: Consider regulatable promoters that respond to carbon source to coordinate LIAS expression with metabolic state
Use genomic integrative cassettes rather than episomic vectors for stable expression
Future directions:
Development of more finely tunable expression systems
Identification of promoters responsive to specific metabolic conditions
Engineering synthetic promoters with multiple regulatory elements
These advances in promoter characterization provide opportunities for more precise control of LIAS expression for both research and biotechnological applications .
Advanced structural biology techniques offer promising avenues for deeper insights into A. gossypii LIAS:
These advanced structural studies could provide unprecedented insights into the catalytic mechanism of LIAS and guide rational engineering approaches for biotechnological applications.
Comparing A. gossypii LIAS with homologs from other organisms reveals important similarities and differences:
Sequence and structural conservation:
All LIAS enzymes contain conserved motifs for binding two [4Fe-4S] clusters
The core radical SAM domain is highly conserved across species
Variations in N- and C-terminal regions may reflect organism-specific interactions
Functional comparison:
| Feature | Bacterial LIAS (LipA) | Human LIAS | A. gossypii LIAS |
|---|---|---|---|
| Localization | Cytoplasmic | Mitochondrial | Mitochondrial |
| Substrate specificity | Lipoyl domains of various proteins | Primarily processes GCSH first | Likely similar to human system |
| Iron-sulfur cluster donors | IscA/SufA | ISCU, ISCA1/2 | Likely ISCU and ISCA homologs |
| Regulatory mechanisms | Part of bacterial lipoate synthesis operon | Regulated with mitochondrial Fe-S proteins | Likely similar to other fungi |
Catalytic mechanism:
Biotechnological implications:
Knowledge from bacterial and human systems can inform A. gossypii research
Species-specific features must be considered when engineering A. gossypii LIAS
Comparative studies could reveal optimizations for biotechnological applications
Understanding these similarities and differences provides context for A. gossypii LIAS research and can guide experimental approaches.
Studies on iron-sulfur cluster transfer in other organisms provide valuable insights for A. gossypii research:
Lessons from Arabidopsis studies:
Competitive utilization of iron-sulfur clusters occurs between different proteins
Deletion of abundant Fe-S proteins (like ACO3) can redirect clusters to less abundant ones (like LIAS)
GRXS15 is critical for [2Fe-2S] cluster transfer, affecting downstream [4Fe-4S] cluster assembly
LIAS activity directly impacts metabolite profiles, with deficiencies causing accumulation of α-keto acids
Insights from human studies:
Bacterial system insights:
The bacterial Fe-S cluster assembly machinery (ISC and SUF systems) shows functional parallels with eukaryotic systems
Bacterial studies have revealed detailed mechanistic insights into radical SAM enzymes like LIAS
Application to A. gossypii research:
Identify and characterize A. gossypii homologs of key Fe-S cluster assembly proteins
Investigate competitive Fe-S cluster utilization in A. gossypii
Consider co-expression of Fe-S cluster assembly proteins when producing recombinant LIAS
Study the impact of LIAS activity on A. gossypii metabolite profiles
This cross-organism knowledge can accelerate A. gossypii LIAS research by providing established frameworks and experimental approaches .
Robust experimental design is critical for understanding LIAS impacts on metabolism:
Key experimental approaches:
Genetic manipulation: Gene deletion, overexpression, and site-directed mutagenesis
Metabolomics: Targeted and untargeted analysis of metabolite profiles
Protein analysis: Assessment of lipoylation status of target proteins
Flux analysis: Measurement of metabolic flux through key pathways
Experimental design principles:
Controls: Include appropriate wild-type and negative controls
Replication: Minimum of three biological replicates per condition
Variables: Control for culture conditions, growth phase, and media composition
Statistical analysis: Apply appropriate statistical methods (e.g., Student's t-test for comparing two conditions, ANOVA for multiple conditions)
Sample experimental design for metabolic impact study:
| Group | Genetic Background | Growth Conditions | Measurements | Replicates |
|---|---|---|---|---|
| Control | Wild-type | Standard media | Metabolites, Lipoylation, Growth | n=5 |
| LIAS↓ | LIAS knockdown | Standard media | Metabolites, Lipoylation, Growth | n=5 |
| LIAS↑ | LIAS overexpression | Standard media | Metabolites, Lipoylation, Growth | n=5 |
| LIAS↓ rescue | LIAS knockdown + complementation | Standard media | Metabolites, Lipoylation, Growth | n=5 |
Key metabolites to measure:
Pyruvate and other α-keto acids (accumulate with LIAS deficiency)
TCA cycle intermediates (affected by PDC and OGDC activity)
Glycine and serine (reflect GCS activity)
Acetyl-CoA and other acyl-CoAs (central to many pathways)
Riboflavin and precursors (industrially relevant)
Data analysis considerations:
This systematic approach will provide robust insights into LIAS's impact on A. gossypii metabolism.
Assessing protein lipoylation status is crucial for LIAS research:
Western blot analysis:
Use anti-lipoic acid antibodies to detect lipoylated proteins
Sample preparation is critical—use protease inhibitors and maintain reducing conditions
Separate mitochondrial proteins by SDS-PAGE
Transfer to PVDF or nitrocellulose membranes
Probe with anti-lipoic acid antibody followed by appropriate secondary antibody
Compare band intensities across samples to quantify relative lipoylation levels
Mass spectrometry approaches:
Bottom-up proteomics: Digest proteins, identify lipoylated peptides by MS/MS
Top-down proteomics: Analyze intact proteins to determine modification stoichiometry
Targeted MRM/PRM: Focus on specific lipoylated peptides for quantitative analysis
Look for mass shifts characteristic of lipoylation (+188 Da) or octanoylation (+126 Da)
Enzyme activity assays:
Measure activities of lipoylation-dependent enzymes (PDC, OGDC, BCKDC, GCS)
Compare activities with total protein levels to infer lipoylation status
Use specific assays for each enzyme complex:
PDC: NADH production from pyruvate
OGDC: NADH production from α-ketoglutarate
GCS: CO₂ release from glycine or serine formation
Example protocol workflow:
a. Sample preparation:
Isolate mitochondria from A. gossypii cultures
Lyse mitochondria in buffer containing protease inhibitors
Determine protein concentration
b. Western blot analysis:
Separate 20-50 μg protein per lane by SDS-PAGE
Transfer to membrane
Block with 5% non-fat milk or BSA
Incubate with anti-lipoic acid antibody (1:1000 dilution)
Wash and incubate with HRP-conjugated secondary antibody
Develop using chemiluminescence and image
c. Quantification:
Normalize lipoylated protein bands to loading control
Compare across samples to determine relative lipoylation levels
Expected results interpretation: